MeSH D006069 - gonorrhea
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| A.H. Robins Company | Erythromycin lactobionate | Erythromycin | 1985-03-28 | |||
| Erythromycin | Robimycin | 1982-01-01 | ||||
| Tetracycline | Tetracycline | 1982-01-01 | ||||
| Abbott Biotherapeutics | Erythromycin lactobionate | Erythrocin | 1988-01-04 | |||
| Tetracycline | Tetracycline | 1982-01-01 | ||||
| Abon Pharmaceuticals | Erythromycin | Erythromycin | 2025-09-23 | |||
| Alembic Pharmaceuticals | Moxifloxacin | Moxifloxacin | 2019-02-13 | |||
| Erythromycin | Erythromycin | 2023-08-24 | ||||
| ALK-Abelló | Ciprofloxacin | Otiprio | 2029-04-21 | 2015-12-10 | ||
| Alkem Laboratories | Cefixime | Cefixime | 2018-10-09 | |||
| Erythromycin | Erythromycin | 2022-07-13 | ||||
| Allergan | Ciprofloxacin | Ciprofloxacin | 2005-01-21 | |||
| Erythromycin estolate | Erythromycin Estolate | 1982-01-01 | ||||
| Erythromycin stearate | Erythromycin Stearate | 1982-01-01 | ||||
| Tetracycline | Tetracycline | 1982-01-01 | ||||
| Alpharma | Erythromycin | Erythromycin | 1982-04-19 | |||
| Erythromycin estolate | Erythromycin Estolate | 1982-11-18 | ||||
| Erythromycin | Erythromycin Ethylsuccinate | 1982-01-01 | ||||
| Tetracycline | Tetracycline | 1982-01-01 | ||||
| Alra | Erythromycin, Sulfisoxazole acetyl | Eryzole | 1988-06-15 |
1
2
3
4
5
6
...
14
>
Clinical Trials
Historical Success Rate
Phase 1
80%4/5
Phase 2
70%7/10
Phase 3
79%33/42
Approved: 29Overall Success rate: 44%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
4
5
6
...
10
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use